Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-27T11:29:29.475Z Has data issue: false hasContentIssue false
  • English
  • Français

Tetralogy of Fallot in a neonate following intrauterine exposure to valproic acid

Published online by Cambridge University Press:  19 August 2008

Wendy A. Stewart  and
R. Michael Giuffre
Wendy A. Stewart
Affiliation:
Division of Pediatric Cardiology, Alberta Children's Hospital, University of Calgary, Calgary
R. Michael Giuffre*
Affiliation:
Division of Pediatric Cardiology, Alberta Children's Hospital, University of Calgary, Calgary
*
Dr. Michael Giuffre, Pediatric Cardiologist, Alberta Children's Hospital, 1820 Richmond Rd, S.W., Calgary, Alberta, Canada T2T 5C7. Tel. 403 229 7211; Fax 403 229 7221.
Get access Rights & Permissions [Opens in a new window]

Summary

Valproic acid is a known teratogen, giving rise to a typical craniofacial appearance, the fetal valproate syndrome. Congenital heart malformations in this syndrome have most commonly been ventricular septal defects. We report a child with familial craniosynostosis, and tetralogy of Fallot, following intrauterine exposure to valproic acid.

Keywords

Tetralogy of Fallotvalproic acidteratogen
Type
Brief Reports
Information
Cardiology in the Young , Volume 6 , Issue 3 , July 1996 , pp. 232 - 234
Copyright
Copyright © Cambridge University Press 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Di, Liberti JH, Farndon, PA, Dennis, HR, Curry, CJR.The fetal valproate syndrome. Am J Med Genet 1984; 19: 473–481.Google Scholar
2.Ardinger, HH, Atkin, JF, Blackston, RD, Elsas, LJ, CLarren, SK, Livingstone, S, Flannery, DB, Pellock, JM, Harrod, MJ, Lammer, EJ, Majewski, F, Schinzel, A, Toriello, HV, Hanson, JW.Verification of the fetal valproate syndrome phenotype. Am J Med Genet 1988; 29: 171–185.CrossRefGoogle ScholarPubMed
3.Jager-Roman, E, Deichl, A, Jakob, S, Hartmann, A-M, Koch, S, Rating, D, Steldinger, R, Nau, H, Helge, H.Fetal growth, major malformations and minor anomalies in infants born to women receiving valproic acid. J Pediatr 1986; 108: 997–1004.CrossRefGoogle ScholarPubMed
4.Thomas, DBuchanan, N.Teratogenicity of anticonvulsants. J Pediatr 1981 99: 163.CrossRefGoogle ScholarPubMed
5.Thisted, E, Ebbesen, F.Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero. Arch Dis Child 1993; 69: 288–291.CrossRefGoogle ScholarPubMed
6.Lin, AE, McPherson, E, Nwokoro, NA, Clemens, M, Losken, HW, Mulvihill, JJ.Further delineation of the Baller-Gerold Syndrome. Am J Med Gen 1993; 45: 519–524.CrossRefGoogle ScholarPubMed
7.Cohen, DM, Green, JG, Miller, J, Gorlin, RJ, Reed, JA.Acrocephalopolysyndactyly Type II–Carpenter Syndrome: Clinical spectrum and an attempt at unification with Goodman and Summit Syndromes. Am J Med Gen 1987; 28: 311–324.CrossRefGoogle Scholar